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ABSTRACT 
Objective: The aim of the present work was to develop a gastro retentive drug delivery system of Ofloxacin with the objective of retarding the drug 
release when the dosage form is exposed to gastrointestinal fluid.  
Methods: Floating tablets of Ofloxacin were developed using a natural gum like Sterculia foetida. The prepared tablets were evaluated in terms of 
their precompression parameters, physical characteristics, in vitro buoyancy, in vitro drug release and release order kinetics. The formulations were 
optimized for different concentrations of Sterculia foetida.  
Results: The results of in vitro release studies showed that optimized formulation (F4) could sustain drug release (97.86%) for 24 h and remain 
buoyant for 24 h. The optimized formulation was subjected to various release kinetic investigations and it was found that the mechanism of drug 
release was predominantly diffusion with a minor contribution from polymeric relaxation.  
Conclusion: Floating tablets of Ofloxacin were successfully formulated with the ability of providing controlled release and non-Fickian transport of 
the drug from tablets was confirmed. 
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INTRODUCTION 
Oral delivery of the drug is the most preferable route of drug 
delivery due to the ease of administration, patient compliance, and 
flexibility in the formulations [1]. To prolong the residence time of 
dosage forms within gastrointestinal tract until all drug is released 
at desired rate is one of the real challenges for oral controlled-
release drug delivery system [2]. In the present era, gastro-retentive 
dosage forms (GRDF) receive great attention because they can 
improve the performance of controlled release systems. An optimum 
GRDF system can be defined as a system which remains in the 
stomach for a sufficient time interval against all the physiological 
barriers, releases active moiety in a controlled manner, and finally is 
easily metabolized in the body. Physiological barriers like gastric 
motility and gastric retention time (GRT) act as obstacles in 
developing an efficient GRDF [3]. Several technical approaches are 
currently utilized in the prolongation of gastric residence time, 
including high density, swelling and expanding, polymeric 
mucoadhesive, ion-exchange, raft forming, magnetic and floating 
drug delivery systems (FDDS), as well as other delayed gastric 
emptying devices [4]. Since decade or two, the development of 
floating drug delivery systems becomes a significant and novel tool 
as having low density than gastric content [5].  
Ofloxacin (9-fluoro-2, 3-dihydro-3-methyl-10 (4-methyl-1-
piperazinyl)-7-oxo-7H pyrido [1,2,3-de]-1,4-benzoxazine-6-
carboxylic-acid) is a synthetic fluoroquinolone derivative, which acts 
by inhibiting the topoisomerase enzyme which is essential in the 
reproduction of the bacterial DNA [6]. Ofloxacin has a short biological 
half-life (8-9 h) and it has been reported that its bioavailability is 
strongly dependent on the local physiology of the gastrointestinal tract 
[7]. It is highly soluble in acidic media and precipitates in alkaline 
media thereby losing its solubility [8]. Hence, gastro retentive floating 
systems of ofloxacin should enhance the bioavailability by retaining it 
in the acidic environment of the stomach.  
Natural polysaccharides are widely used in the pharmaceutical and 
food industries as excipients and additives due to their low toxicity, 
biodegradability, bio-competitiveness, availability, and low cost. In 
the current investigations, the suitability of Sterculia foetida gum 
which has been reported as a controlled release matrix polymer was 
evaluated in the development of gastro retentive floating drug 
delivery systems (GRFDDS) [9].  
MATERIALS AND METHODS 
Ofloxacin was obtained as a gift sample from Zim Laboratories Ltd., 
Kalmeshwar, Maharashtra. The Gum of Sterculia foetida 
(Sterculiaceae) was procured from the vendor M/s Mr. Wagh 
Brothers, Nagpur. The gum was authenticated and approved after 
macroscopical and microscopical evaluation by Dr. Vinayak R. Naik, 
Senior Research Scientist, Nicholas Piramal Life Sciences Ltd., 
Mumbai. The said gum was used for the research work. All other 
chemicals used in the study were of analytical grade. 
Preformulation studies 
Drug excipient compatibility studies 
The compatibility studies provide the basis for selecting the right 
combination of drug and the excipients. Thus, the pure drug and 
physical mixture of drug and polymers were subjected to IR 
spectroscopic study using FT-IR spectrophotometer (IR Affinity-1, 
Shimadzu). The spectra were scanned over the wave number range 
from 4000–400 cm-1. Additionally, the DSC thermograms of the pure 
drug, polymer and physical mixture of the drug and the polymer were 
recorded using differential scanning calorimeter (Perkin Elmer, USA). 
The samples were heated in an open aluminum pan from 40 to 300 °C 
at a scanning rate of 10 °C/min under the stream of nitrogen.  
Formulation of ofloxacin floating tablets  
Ofloxacin floating tablets were prepared as per the composition is 
shown in table 1. The ingredients were weighed accurately and mixed 
thoroughly. Granulation was done with the help of water. The granules 
were dried in conventional hot air oven at 50oC. Drying of the granules 
was stopped when the sample taken from the oven reached a loss on 
drying (LOD) value of 1 to 3%, as measured by a moisture balance at 
105 °C. The dried granules were sized through 16 mesh, lubricated 
with magnesium stearate and purified talc and then compressed. 
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Table 1: Composition of floating tablet formulation of ofloxacin 
S. No. Ingredients (mg/tablet) F1 10 %w/w F2 20 %w/w F3 30 %w/w F4 40 %w/w 
1 Ofloxacin 100 100 100 100 
2 Sterculia foetida Gum 50 100 150 200 
3 Lactose 290 240 190 140 
4 Sodium bicarbonate 50 50 50 50 
6 Magnesium stearate 5 5 5 5 
7 Talc 5 5 5 5 
8 Water q. s. q. s. q. s. q. s. 
9 Total 500 500 500 500 
 
Evaluation of floating tablets 
Determination of precompression parameters  
The flow properties of granules (before compression) were 
characterized for micrometric properties in terms of angle of repose, 
tapped density, bulk density, Carr’s index and Hausner ratio [10, 11]. 
Determination of post compression parameters of floating 
tablets 
Ofloxacin floating tablets were subjected to determination of post-
compression parameters like hardness, weight variation and friability 
[12-14]. Ten tablets were selected at random, and the hardness of each 
tablet was measured on Monsanto hardness tester. Thickness and 
diameter of ten tablets were measured using Vernier callipers. Twenty 
tablets were selected at random, weighed together and individually to 
check for weight variation. The friability of the tablets was determined 
using Roche’s friabilator. Twenty tablets were accurately weighed and 
placed in the friabilator and operated for 100 revolutions. The tablets 
were deducted and reweighed. The tablets that loose less than 1% 
weight were considered to be compliant.  
% friability = Initial weight−Final weight
Initial weight 
 × 100 
Drug content estimation 
The drug content in each formulation was determined by triturating 20 
tablets, and powder equivalent to average weight was added in 100 ml of 
0.1M hydrochloric acid, followed by stirring. The solution was filtered 
through a 0.45μ membrane filter, diluted suitably and the absorbance of 
the resultant solution was measured spectrophotometrically at 297 nm 
using 0.1 M hydrochloric acid as blank [15].  
In vitro buoyancy studies 
The in vitro buoyancy was determined by the floating lag time. The 
tablets were placed in 100-mL beaker containing 0.1M HCL. The 
time required for the tablet to rise to the surface for floating was 
determined as the floating lag time and further floating duration of 
all tablets was determined by visual observations [16, 17].  
In vitro dissolution studies 
The release rate of Ofloxacin from floating tablets was determined 
using USP Type II apparatus (TDT-08L, Electrolab, India) [18]. The 
dissolution test was performed using 900 ml of 0.1M hydrochloric 
acid, at 37±0.5 °C and 50 rpm. A sample (10 ml) of the solution was 
withdrawn from the dissolution apparatus hourly and during each 
withdrawal, the samples were replaced with fresh dissolution 
medium. The samples were filtered through a 0.45μ membrane filter 
and diluted to a suitable concentration with 0.1N hydrochloric acid. 
The absorbance of these solutions was measured at 297 nm using a 
UV-Visible spectrophotometer. The percentage drug release was 
plotted against time to determine the release profile. 
Drug release kinetics  
The kinetic model had described drug dissolution from solid dosage 
form where the dissolved amount of drug is a function of test time. 
In order to study the exact mechanism of drug release from the 
tablets, the in vitro drug release data was analyzed according to zero 
order, first order, Higuchi square root, Korsmeyer-Peppas model 
[19-21]. The criteria for selecting the most appropriate model were 
chosen on the basis of goodness of fit test. The data were processed 
for regression analysis using graph pad prism.  
RESULTS AND DISCUSSION 
Drug-polymer compatibility studies 
The drug and excipients must be compatible with one another to 
produce a product that is stable, efficacious, attractive, easy to 
administer and safe. The major FT-IR peaks observed in Ofloxacin 
were-OH stretch (3100 cm-1), N-CH3 (2750 cm-1), C=O (1725 cm-1),-F 
(1175 cm-1),-CN stretch (850 cm-1), FT-IR peaks observed in physical 
mixture of Ofloxacin and Sterculia foetida gum were-OH stretch 
(3150 cm-1), N-CH3 (2800 cm-1),-C=O (1700 cm-1),-F (1175 cm-1),-CN 
stretch (850 cm-1), as shown in fig. 1 and 2 respectively. No extra 
peaks were observed in the spectrum which inferred that the chosen 
natural gum was compatible with Ofloxacin. Compatibility studies 
were also carried out using DSC, which allows determination of 
thermotropic phase transition behavior in a quantitative manner. 
The thermograms recorded during analysis display pronounced 
melting peaks. The narrow peak at 268.75 °C for Ofloxacin (fig. 3A) 
infers the presence of a crystalline form of the drug. The 
thermogram of Sterculia foetida displayed a slight peak at 288.23 ºC 
(fig. 3B). The physical mixture of the drug and the carrier retained 
the crystalline peak of the drug (fig. 3C) demonstrating clearly the 
compatibility of Ofloxacin with the said gum. 
 
 
Fig. 1: FT-IR spectrum of Ofloxacin 
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Fig. 2: FT-IR spectrum of physical mixture of Ofloxacin and Sterculia foetida gum 
 
 
Fig. 3: DSC thermogram of (A) Ofloxacin (B) Sterculia foetida gum 
and (C) Physical mixture of Ofloxacin and Sterculia foetida gum 
Determination of precompression parameters  
Table 2 depicts the precompression parameters of Ofloxacin 
granules. The granules showed good flow property. The angle of 
repose ranged from 21 °±0.8 to 24 °±0.7 and the compressibility 
index ranged from 9.91±0.32 to 14.58±0.74. The bulk density and 
tapped density of the prepared granules ranged from 0.322±0.011 to 
0.333±0.113 and 0.363±0.038 to 0.377±0.041 respectively. The 
results of the angle of repose indicated good flow property of the 
granules and the value of compressibility index and Hausner’s ratio 
further showed support for the good flow property. 
Determination of post compression parameters of floating tablets 
The results of post compression parameters of Ofloxacin floating 
tablets are as shown in the table 3. The thickness of tablets was 
measured by Vernier calipers and ranged between 4.80±0.01 to 
4.85±0.01 mm, respectively. The hardness of the tablets was 
measured by Monsanto hardness tester and ranged in between 
4.2±0.27 to 5.0±0.35 kg/cm2. The friability was found to be 
0.59±0.05 to 0.95±0.06 %, which is an indication of the satisfactory 
mechanical resistance of the tablets as shown in the table 3. All the 
formulations showed values within the prescribed limits for tests 
like hardness, friability, and weight variation which indicate that the 
prepared tablets are of standard quality. 
Drug content estimation 
The drug content estimations showed values in the range of 
96.4±0.006 to 99.4±0.002 % (Table4) which reflects good 
uniformity in drug content among different formulations. 
 
Table 2: Precompression parameters of ofloxacin granules 
Formulation code Evaluation parameters 
Bulk density (g/cc)  Tapped density (g/cc)  Angle of repose (θ)  Carr’s index Hausner’s ratio 
F1 0.322±0.011 0.377±0.041 24 °±0.7 14.58±0.74 1.17±0.32 
F2 0.327±0.005 0.370±0.096 23 °±1.0 11.62±0.52 1.13±0.27 
F3 0.333±0.113 0.370±0.013 23 °±0.4 10.0±0.79 1.11±0.15 
F4 0.327±0.035 0.363±0.038 21 °±0.8 9.91±0.32 1.11±0.54 
Data expressed as mean±SD; n=3 
 
Table 3: Evaluation of post-compression properties of floating tablets 
Formulation Code Evaluation parameters (mean±SD) 
Thickness (mm), n=10 Hardness (Kg/cm2), n=10 Friability (%) n=20 Weight variation(g), n=20 
F1 4.84±0.01 4.2±0.27 0.95±0.06 0.493±1.78 
F2 4.82±0.35 4.5±0.35 0.80±0.08 0.496±0.57 
F3 4.80±0.01 4.6±0.22 0.72±0.03 0.496±0.67 
F4 4.85±0.01 5.0±0.35 0.59±0.05 0.496±1.92 
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Table 4: Estimation of drug content 
Formulation code Calculated value (mg) Estimated value (mg)  % Drug content 
F1 100 96.4±0.003 96.4±0.006 
F2 100 97.9±0.005 97.9±0.004 
F3 100 98.4±0.006 98.4±0.005 
F4 100 99.4±0.004 99.4±0.002 
Data expressed as mean±SD; n=3 
 
In vitro buoyancy studies 
All the tablets were prepared by the effervescent approach. Sodium 
bicarbonate was added as a gas-generating agent. Sodium 
bicarbonate induced carbon dioxide generation in the presence of 
dissolution medium (0.1 M hydrochloric acid). It was observed that 
the gas generated was trapped and protected within the gel, thus 
decreasing the density of the tablet below 1 and as a result, the 
tablet became buoyant. The tablet swelled radially and axially 
during in vitro buoyancy studies. In this study it was observed, an 
increase in the concentration of Sterculia foetida gum decreased the 
floating lag time (table 5). Thus, the results indicated that as the 
concentration of polymer increased, floating lag time decreased due 
to the hydrophilic nature of polymer which allowed the penetration 
of media through the pores formed on the surface of the tablet and 
total floating time increased due to the swelling nature of the tablet 
which kept it intact for a longer duration. Similar observations have 
been reported earlier [22]. 
In vitro dissolution studies 
In vitro dissolution studies of all the formulations of floating tablets 
of Ofloxacin were carried out in 0.1N HCl. The study was performed 
for 24h and cumulative drug release was calculated at every one 
hour time interval. In vitro dissolution studies of all the formulations 
are shown in fig. 4. A natural gum was used to prepare floating 
tablets. It was observed that the type of natural gum influences the 
drug release pattern. All the formulations contained gas generating 
agent (sodium bicarbonate). A significantly higher rate and extent of 
drug release were observed from the batches based on Sterculia 
foetida gum. Varying the amount of Sterculia foetida gum affected the 
drug release. Moreover, tablets formulated using Sterculia foetida gum 
(formulation F1) could not bear their matrix shapes until 24 h and the 
released the drug before 24 h. Among the tablets F2-F4, an increasing 
concentration of Sterculia foetida gum was present, and it was found 
that the formulation F4 sustained the drug release up to 24 h. Thus, 
formulation F4 was considered as the optimized formulation based on 
drug release and in vitro buoyancy studies. 
 
 
Fig. 4: Comparative in vitro dissolution profiles of floating 
tablets (formulation F1-F4) 
  
Table 5: In vitro buoyancy studies of floating tablets 
Formulation code Floating lag time (sec) Total floating time (hr) 
F1 255±2.06 >23 
F2 110±1.0 >24 
F3 65±0.57 > 24 
F4 35±1.52 > 24 
 Data expressed as mean±SD; n=3 
 
Table 6: Kinetic release data of different model for optimized formulation (F4) 
Model Slope R2 
Zero order 0.663 0.9984 
First order 0.713 0.8744 
Higuchi 0.567 0.9319 
Korsmeyer-Peppas 0.659 0.9876 
 
Drug release kinetics  
The drug release data of optimized formulation (F4) were fitted to 
models representing Higuchi’s, zero order, first order and 
Korsmeyer’s equation kinetics to know the release mechanisms. The 
data were processed for regression analysis using Graph pad prism 
statistical function. The results are shown in table 6. In the present 
study, in vitro release profiles could be best expressed by zero-order 
equation, as optimized formulation (F4) showed good linearity (R2= 
0.9984) indicating diffusion as the dominant mechanism of drug 
release from the formulations. The values of slope for the 
korsemeyer-Peppas model indicated that the drug release from the 
tablets was non fickian diffusion. 
CONCLUSION 
In the present study, Ofloxacin floating tablets were formulated by 
wet granulation method using a natural gum like Sterculia foetida. 
Formulation (F4) containing Sterculia foetida showed controlled 
drug release for 24 h, emerging as best formulation. Mechanism of 
drug release of optimized formulation (F4) was found to be Zero 
order with non Fickian diffusion.  
The present study, in conclusion, highlights the potential application 
of a plant-based polymer as a viable replacement for synthetic 
polymers in the development of controlled release dosage forms. 
Formulations prepared by such economical, renewable and eco-
friendly plant resources can be considered to contain promising 
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controlled release polymer substances with the ability to bring 
about desired drug release supported by more elaborated research 
in this aspect. 
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